{
    "ticker": "CDXS",
    "name": "Codexis, Inc.",
    "description": "Codexis, Inc. is a leading biotechnology company that specializes in the development of innovative enzyme solutions for various industries, including pharmaceuticals, food, and biofuels. Founded in 2002 and headquartered in Redwood City, California, Codexis leverages its proprietary CodeEvolver\u00ae technology platform to design and optimize enzymes, which are essential for accelerating chemical reactions in biological processes. The company's mission is to improve health and sustainability through biotechnology by providing high-performance enzymes that enhance production efficiency and reduce environmental impact. Codexis has established partnerships with numerous companies to create custom enzyme solutions that meet specific industrial needs, significantly contributing to advancements in drug manufacturing and sustainable practices. With a commitment to research and development, Codexis continues to expand its enzyme portfolio and explore new applications across diverse sectors. The company aims to lead the transformation of the biotechnology landscape, focusing on sustainable and efficient production methods that can benefit both industries and consumers.",
    "industry": [
        "Biotechnology",
        "Pharmaceuticals",
        "Industrial Enzymes"
    ],
    "headquarters": "Redwood City, California, USA",
    "founded": "2002",
    "website": "https://www.codexis.com",
    "ceo": "John Nicols",
    "social_media": {
        "twitter": "https://twitter.com/Codexis",
        "linkedin": "https://www.linkedin.com/company/codexis"
    },
    "investor_relations": "https://ir.codexis.com",
    "key_executives": [
        {
            "name": "John Nicols",
            "position": "CEO"
        },
        {
            "name": "Kurt E. Von Emster",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Pharmaceutical Enzymes",
            "products": [
                "Vibrant\u2122",
                "Codexis Enzyme Products"
            ]
        },
        {
            "category": "Industrial Enzymes",
            "products": [
                "Codexis Enzyme Solutions"
            ]
        }
    ],
    "seo": {
        "meta_title": "Codexis, Inc. | Innovative Enzyme Solutions for Biotechnology",
        "meta_description": "Explore Codexis, Inc., a leader in biotechnology known for its enzyme solutions that enhance production efficiency in pharmaceuticals and other industries.",
        "keywords": [
            "Codexis",
            "Biotechnology",
            "Enzymes",
            "Pharmaceuticals",
            "Sustainable Production"
        ]
    },
    "faq": [
        {
            "question": "What is Codexis known for?",
            "answer": "Codexis is known for its innovative enzyme solutions that improve efficiency in various industries, including pharmaceuticals and biofuels."
        },
        {
            "question": "Who is the CEO of Codexis?",
            "answer": "John Nicols is the CEO of Codexis, Inc."
        },
        {
            "question": "Where is Codexis headquartered?",
            "answer": "Codexis is headquartered in Redwood City, California, USA."
        },
        {
            "question": "What are Codexis's main products?",
            "answer": "Codexis's main products include pharmaceutical enzymes and industrial enzyme solutions."
        },
        {
            "question": "When was Codexis founded?",
            "answer": "Codexis was founded in 2002."
        }
    ],
    "competitors": [
        "AMRS",
        "ENSG",
        "LGCY"
    ],
    "related_stocks": [
        "VRTX",
        "REGN",
        "ALNY",
        "CRIS"
    ]
}